Clinical trial · Interventional
Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients
NCT04771559CI-TRIAL-00053056completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to evaluate the effects and side effects of inactive COVID-19 vaccine in patients with cancer and compare them with the healthy control group.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Covid19 | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| COVID-19 antibody test | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Cancer patients
- description
- Covid-19 antibody levels of patients will be measured
- interventionNames
- Other: COVID-19 antibody test
- type
- OTHER
- label
- Healthy control
- description
- Covid-19 antibody levels of healthy controls will be measured
- interventionNames
- Other: COVID-19 antibody test
Primary outcomes (1)
- measure
- Antibody levels
- timeFrame
- 1 month
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: For the patient group : 1. Patients with pathological and clinical cancer diagnosis 2. Older than 18 years 3. Patients two doses of COVID-19 vaccine administered 4. Volunteering to participate in the study For the control group : 1. No known cancer diagnosis or history 2. Older than 18 years 3. Two doses of COVID-19 vaccine administered 4. Volunteering to participate in the study - Exclusion Criteria: 1. Not volunteering to participate in the study 2. \< 18 years 3. Not administered two doses of the COVID-19 vaccine 4. Covid-19 infection history -
References
Publications (1)
- DERIVEDYasin AI, Aydin SG, Sumbul B, Koral L, Simsek M, Geredeli C, Ozturk A, Perkin P, Demirtas D, Erdemoglu E, Hacibekiroglu I, Cakir E, Tanrikulu E, Coban E, Ozcelik M, Celik S, Teker F, Aksoy A, Firat ST, Tekin O, Kalkan Z, Turken O, Oven BB, Dane F, Bilici A, Isikdogan A, Seker M, Turk HM, Gumus M. Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study. Future Oncol. 2022 Mar;18(10):1235-1244. doi: 10.2217/fon-2021-1248. Epub 2022 Jan 27. PMID 35081732